RMAH.RO · BVB
Farmaceutica Remedia: financial statements
Financially weak · see the checkFigures in RON, fiscal years
Revenue and net income
Operating and free cash flow
Margins
Returns
Income statement
| RON | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Last year |
|---|---|---|---|---|---|---|---|
| Revenue | 483M RON | 478M RON | 540M RON | 600M RON | 748M RON | 766M RON | +2% |
| Gross profit | 30.6M RON | 9.2M RON | 10.2M RON | 13.0M RON | 12.6M RON | 12.6M RON | +0% |
| Operating income | 42.9M RON | 8.8M RON | 6.7M RON | 8.2M RON | 13.1M RON | 14.7M RON | +13% |
| EBITDA | 45.5M RON | 10.6M RON | 10.8M RON | 13.7M RON | 16.4M RON | 17.5M RON | +7% |
| Interest expense | 103K RON | 0 RON | 162K RON | 53.6K RON | 0 RON | 0 RON | |
| Profit before tax | 42.8M RON | 8.6M RON | 7.1M RON | 8.9M RON | 14.1M RON | 16.2M RON | +15% |
| Income tax | 5.0M RON | 1.4M RON | 1.2M RON | 1.7M RON | 7.1M RON | 8.2M RON | +15% |
| Net income | 37.8M RON | 7.2M RON | 5.8M RON | 7.2M RON | 7.0M RON | 8.0M RON | +15% |
Cash flow
| RON | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Last year |
|---|---|---|---|---|---|---|---|
| Operating cash flow | — | -2.6M RON | 2.0M RON | 23.2M RON | 19.0M RON | 15.5M RON | -18% |
| Free cash flow | — | -2.6M RON | 2.0M RON | 23.2M RON | 19.0M RON | 15.5M RON | -18% |
| Depreciation & amortization | 2.6M RON | 1.8M RON | 4.1M RON | 5.5M RON | 3.3M RON | 2.8M RON | -15% |
Balance sheet
| RON | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Last year |
|---|---|---|---|---|---|---|---|
| Cash | 34.4M RON | 24.2M RON | 18.1M RON | 34.5M RON | 47.7M RON | 57.9M RON | +22% |
| Inventory | 35.1M RON | 40.6M RON | 46.3M RON | 44.3M RON | 57.2M RON | 63.4M RON | +11% |
| Current assets | 203M RON | 206M RON | 241M RON | 268M RON | 327M RON | 331M RON | +1% |
| Total assets | 244M RON | 251M RON | 286M RON | 316M RON | 375M RON | 383M RON | +2% |
| Current liabilities | 162M RON | 180M RON | 215M RON | 239M RON | 296M RON | 298M RON | +1% |
| Financial debt | 0 RON | 0 RON | 0 RON | 0 RON | 0 RON | 0 RON | |
| Total liabilities | 165M RON | 183M RON | 218M RON | 245M RON | 301M RON | 304M RON | +1% |
| Shareholders' equity | 79.8M RON | 68.2M RON | 68.4M RON | 70.9M RON | 73.9M RON | 79.6M RON | +8% |
| Net debt | -34.4M RON | -24.2M RON | -18.1M RON | -34.5M RON | -47.7M RON | -57.9M RON | -22% |
Dividend profile
- Paying in a row
- 5 years
- Raised in a row
- 0 years
- Growth per year
- n/a
- Paid out of profit
- 62.3%
- Paid out of free cash
- 24.0%
Without share prices EdgeScore shows no dividend yield.
Dividends
| RON | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Last year |
|---|---|---|---|---|---|---|---|
| Dividends paid | — | 13.4M RON | 4.5M RON | 4.2M RON | 6.3M RON | 3.4M RON | -47% |
| Dividends / net income | — | 184.6% | 76.9% | 58.2% | 90.3% | 41.7% | |
| Dividends / free cash flow | — | — | 224.8% | 18.0% | 33.2% | 21.6% |
Ratios
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Last year | |
|---|---|---|---|---|---|---|---|
| Gross margin | 6.3% | 1.9% | 1.9% | 2.2% | 1.7% | 1.6% | |
| Operating margin | 8.9% | 1.8% | 1.2% | 1.4% | 1.8% | 1.9% | |
| Net margin | 7.8% | 1.5% | 1.1% | 1.2% | 0.9% | 1.0% | |
| Return on equity | 47.3% | 10.6% | 8.5% | 10.2% | 9.4% | 10.1% | |
| Return on assets | 15.5% | 2.9% | 2.0% | 2.3% | 1.9% | 2.1% | |
| Return on invested capital | 83.2% | 16.5% | 11.8% | 15.2% | 33.0% | 48.5% | |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net debt / EBITDA | -0.8x | -2.3x | -1.7x | -2.5x | -2.9x | -3.3x | |
| Interest coverage | 417.0x | — | 41.6x | 152.2x | — | — | |
| Current ratio | 1.25 | 1.14 | 1.12 | 1.12 | 1.11 | 1.11 | |
| Quick ratio | 1.03 | 0.92 | 0.91 | 0.94 | 0.91 | 0.90 |
Data source: Bucharest Stock Exchange (ESEF), company annual reports. Lines a company does not report are left empty. Free cash flow is operating cash flow minus capital expenditure. Ratios use the same formulas as the EdgeScore check.
For information and education only. Not investment advice. Data may contain errors.